Market-Moving Exclusives Archives - Page 16 of 22

1 minute read

EXCLUSIVE: Ocean Biomedical Highlights New Results From Anti-Cancer Antibody Validating Tumor Suppression In Animal Models With Brain Tumor

April 27, 7:30 AM

Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder, Jack Elias, published new findings in the peer-reviewed journal Cancer Research detailing the mechanisms behind the role of chitinase 3-like-1 (Chi3L1) in the growth of glioblastoma tumors.

OCEA

2 minute read

EXCLUSIVE: SAB Biotherapeutics Releases Topline Data From Discontinued COVID Antibody Trial

By Vandana Singh

April 26, 8:00 AM

SAB Biotherapeutics Inc (NASDAQ: SABS) has revealed topline results from the Phase 3 National Institutes of Health's (NIH) ACTIV-2 trial that assessed SAB-185 in non-hospitalized COVID-19 patients at high risk for severe outcomes.

REGN

1 minute read

EXCLUSIVE: Ocean Biomedical’s Co-Founder Outlines Detailed Data From Malaria Vaccine At Conference

By Vandana Singh

April 25, 7:30 AM

Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder, Jonathan Kurtis, presented details of the company's malaria vaccine and treatment approach at the PATH Malaria's annual retreat in Washington, DC.

OCEA

1 minute read

EXCLUSIVE: BioRestorative Concludes Enrollment For Safety Run-In Component Of Cell Therapy Study For Chronic Lower Back Pain

By Vandana Singh

April 24, 6:30 AM

BioRestorative Therapies Inc (NASDAQ: BRTX) has completed enrollment for the safety run-in component of its Phase 2 study of BRTX-100 targeting patients suffering from chronic lumbar disc disease (cLDD).

BRTX

1 minute read

EXCLUSIVE: Ocean Biomedical’s Co-Founder Jack Elias To Receive US Patent For Lung Fibrosis Therapeutics

By Vandana Singh

April 20, 7:30 AM

Ocean Biomedical Inc's (NASDAQ: OCEA) co-founder Jack Elias, received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for his U.S. patent application covering a therapeutic molecule for pulmonary fibrosis.

OCEA

2 minute read

EXCLUSIVE: Cepton Launches Proprietary Chipset for Automotive Lidar Dubbed “Komodo” To Boost Cloud Quality And Reduce Costs

By Anusuya Lahiri

April 19, 6:00 AM

Cepton Inc (NASDAQ: CPTN) released Komodo, its proprietary lidar point cloud processor Application-Specific Integrated Circuit (ASIC) chip.

CPTN

1 minute read

EXCLUSIVE: SAB Biotherapeutics Secures FDA Breakthrough Therapy Tag For Its Influenza Immunotherapy

By Vandana Singh

April 18, 8:00 AM

The FDA has granted Breakthrough Therapy Designation (BTD) to SAB Biotherapeutics Inc's (NASDAQ: SABS) SAB-176, an investigational therapy for post-exposure prophylaxis for Type A and Type B influenza illness in high-risk patients, including antiviral resistant strains.

SABS

2 minute read

EXCLUSIVE: Ocean Biomedical Bags $134M Backing For Innovative Research and IND Fillings

By Anusuya Lahiri

April 17, 7:30 AM

Ocean Biomedical, Inc (NASDAQ: OCEA) shared updates on crucial company activities with Benzinga on Monday.

OCEA

2 minute read

Meta Materials Prices $25M Public Offering Of 83,333,334 Shares At A Price Of $0.30/Share And Accompanying Warrant

By Benzinga Newsdesk

April 14, 8:34 AM

Meta Materials Inc.

MMAT

1 minute read

EXCLUSIVE: FDA Grants Expedited Review Status To SAB Biotherapeutics’ Influenza Antibody

By Vandana Singh

April 13, 8:00 AM

The FDA has granted Fast Track designation for SAB Biotherapeutics' (NASDAQ: SABS) SAB-176, an investigational therapeutic for Type A and Type B influenza illness in high-risk patients, including those who have anti-viral resistant strains.

RHHBF